Fundraising Fox
Corvus Pharmaceuticals
Burlingame, US · Founded 2014 · 53 employees on LinkedIn · 3 known investors
Find your way into Corvus Pharmaceuticals
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ran Xiao to introduce you to Richard A. Miller
You →Ran · together at Corvus Pharmaceuticals →Richard
Sign up to find every way you can get introduced to Corvus Pharmaceuticals
- Your email: who you already know at Corvus Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Corvus Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.
Founders & leadership
Corvus Pharmaceuticals was founded in 2014 by Richard A. Miller.
Board
Investors · 3
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$87.7M disclosed across 2 rounds · 2014–2015
▶$75MraisedSep 2015 · 33 investors · Other Health CareRule 506(b)
- Leiv LeaExecutive Officer
- Elisha (Terry) P. GouldDirector
- Peter MoldtDirector
- Peter ThompsonDirector
- Richard A. MillerExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $75M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$12.7MraisedDec 2014 · 12 investors · Other Health CareRule 506(b)
- Richard A. MillerExecutive Officer, Director
- Terry G. GouldDirector
- Leiv LeaExecutive Officer
- Peter ThompsonDirector
- Offering amount
- $33.5M
- Amount sold
- $12.7M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Corvus Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- What does Corvus Pharmaceuticals do?
- Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.
- Who founded Corvus Pharmaceuticals?
- Corvus Pharmaceuticals was founded by Richard A. Miller in 2014.
- Who are Corvus Pharmaceuticals's investors?
- Corvus Pharmaceuticals's investors include Avoro Capital Advisors, Foresite Capital, OrbiMed.
- How much funding has Corvus Pharmaceuticals raised?
- Corvus Pharmaceuticals has disclosed $87.7M raised across 2 rounds.
- Where is Corvus Pharmaceuticals headquartered?
- Corvus Pharmaceuticals is headquartered in Burlingame, US.